111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
38.39B
The estimated revenue has increased from the previous period.
6.05B
The estimated EBITDA has increased from the previous period.
5.53
The estimated EPS has increased from the previous period.
3.97B
The estimated net income has increased from the previous period.
3.91B
The estimated EBIT has increased from the previous period.
8.60B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
36.27B
Revenue has increased from the previous period.
6.80%
Revenue growth rate has increased from the previous period.
6.25B
EBITDA has increased from the previous period.
17.23%
EBITDA margin has increased from the previous period.
4.56B
EBIT has increased from the previous period.
12.56%
EBIT margin has increased from the previous period.
1.69B
Depreciation has increased from the previous period.
6.58B
Total cash has increased from the previous period.
18.14%
Cash percentage is unchanged from the previous period.
4.68B
Receivables have increased from the previous period.
12.90%
Receivables percentage has decreased from the previous period.
4.45B
Inventories have increased from the previous period.
12.28%
Inventory percentage has decreased from the previous period.
3.27B
Accounts payable has increased from the previous period.
9.01%
Payables percentage has increased from the previous period.
-1.89B
Capital expenditure has increased from the previous period.
-5.20%
CapEx percentage has increased from the previous period.
9.67%
WACC has increased from the previous period.
10.90%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
1.38
Beta is unchanged from the previous period.
729.20M
Diluted shares outstanding is unchanged from the previous period.
13.52B
Total debt is unchanged from the previous period.
68.33B
Total equity is unchanged from the previous period.
81.85B
Total capital is unchanged from the previous period.
16.51%
Debt weighting is unchanged from the previous period.
83.49%
Equity weighting is unchanged from the previous period.
3.61B
EBIAT has increased from the previous period.
3.33B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
56.34B
Terminal value is unchanged from the previous period.
50.68B
Enterprise value has decreased from the previous period.
6.94B
Net debt is unchanged from the previous period.
43.74B
Equity value has decreased from the previous period.
59.98
Equity value per share has decreased from the previous period.
